GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NUTEX Investments PLC (BUD:NUTEX) » Definitions » Median PS Value

NUTEX Investments (BUD:NUTEX) Median PS Value : Ft0.27 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is NUTEX Investments Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. NUTEX Investments's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was Ft0.003. NUTEX Investments's 10-Year median PS Ratio is 90. Therefore, the Median PS Value for today is Ft0.27.

As of today (2024-04-27), NUTEX Investments's share price is Ft14.35. NUTEX Investments's Median PS Value is Ft0.27. Therefore, NUTEX Investments's Price to Median PS Value for today is 53.15.

The historical rank and industry rank for NUTEX Investments's Median PS Value or its related term are showing as below:

BUD:NUTEX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 51.48   Med: 745   Max: 2395
Current: 53.15

During the past 13 years, the highest Price to Median PS Value of NUTEX Investments was 2395.00. The lowest was 51.48. And the median was 745.00.

BUD:NUTEX's Price-to-Median-PS-Value is ranked worse than
99.8% of 500 companies
in the Drug Manufacturers industry
Industry Median: 0.8 vs BUD:NUTEX: 53.15

NUTEX Investments Median PS Value Historical Data

The historical data trend for NUTEX Investments's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NUTEX Investments Median PS Value Chart

NUTEX Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.02 0.07 0.27

NUTEX Investments Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - 0.07 - 0.27

Competitive Comparison of NUTEX Investments's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's Price-to-Median-PS-Value falls into.



NUTEX Investments Median PS Value Calculation

NUTEX Investments's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.003*90
=0.27

10-Year Median PS Ratio is 90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was Ft0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments  (BUD:NUTEX) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

NUTEX Investments's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=14.35/0.27
=53.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments Median PS Value Related Terms

Thank you for viewing the detailed overview of NUTEX Investments's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


NUTEX Investments (BUD:NUTEX) Business Description

Traded in Other Exchanges
N/A
Address
Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

NUTEX Investments (BUD:NUTEX) Headlines

No Headlines